Literature DB >> 22062440

Hormone replacement therapy in the geriatric patient: current state of the evidence and questions for the future. Estrogen, progesterone, testosterone, and thyroid hormone augmentation in geriatric clinical practice: part 1.

Erika Schwartz1, Kent Holtorf.   

Abstract

This article presents an up-to-date review of the literature on hormone augmentation in the elderly to help primary care physicians better evaluate and utilize hormone replacement and optimization strategies to benefit their patients. The scientific literature suggests that hormone supplementation with estrogen, progesterone, testosterone, growth hormone, and thyroid hormone has the potential to improve quality of life and to prevent, or reverse, the many symptoms and conditions associated with aging, including fatigue, depression, weight gain,frailty, osteoporosis, loss of libido, and heart disease. Possible long-term side effects are also considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22062440     DOI: 10.1016/j.cger.2011.07.013

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  3 in total

1.  Aging increases CCN1 expression leading to muscle senescence.

Authors:  Jie Du; Janet D Klein; Faten Hassounah; Jin Zhang; Cong Zhang; Xiaonan H Wang
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

2.  MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways.

Authors:  Zhaoyong Hu; Janet D Klein; William E Mitch; Liping Zhang; Ivan Martinez; Xiaonan H Wang
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

3.  Improvement of andropause symptoms by dandelion and rooibos extract complex CRS-10 in aging male.

Authors:  Yoo-Hun Noh; Do-Hee Kim; Joon Yub Kim; Jiae Park; Ok Hyeon Kim; Daeseok Han; Won-Yong Kim; Sung-Su Kim; Moo-Yeol Lee; Seok-Hyun Heo; Misook Kim; Won Bok Lee; Yoonhwa Jeong; Soon Chul Myung
Journal:  Nutr Res Pract       Date:  2012-12-31       Impact factor: 1.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.